Caracterizaçăo clínica e demográfica de pacientes com doença falciforme acompanhados na Fundaçăo Hospitalar de Hematologia e Hemoterapia do Amazonas - HEMOAM
Carregando...
Arquivos
Data
Autores
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade do Estado do Amazonas
Resumo
Sickle cell disease (SCD) is an autosomal recessive disease characterized by the
inheritance of a homozygous mutation in the beta globin gene (HBB), that causes replacement of
glutamic acid at position 6 of the beta globin chain by valine. This alteration results in formation
of an abnormal hemoglobin (HbS), which in deoxygenated form undergoes polymerization
leading to sickling of red blood cells. Clinically SCD is characterized by painful seizures caused
by vaso-occlusion in the microcirculation resulting in acute and chronic lesions in various organs
and tissues such as heart, lungs, bones, kidneys, liver, retina and skin. In addition, patients with
SCD are more susceptible to bacterial infections due to splenic dysfunction secondary to
multiple infarctions, which often leads to functional asplenia or autosplenectomy. SCD is today
seen essentially as an inflammatory disease secondary to the vaso-occlusion process. This
makes the effect of other genetic traits that modulate the inflammatory response in SCD’s
clinical presentation relevant. Recently prediction of the SCD has improved significantly, thanks
to early diagnosis through neonatal screening, improvement of treatment centers, systematic use
of blood products and iron chelators, as well as treatment with hydroxyurea. These new
developments have improved the quality of life of the patients reducing the number of critical
cases and hospitalizations. Despite all the new available therapies, the level of attention and the
therapeutic options are still insufficient, since most of the patients suffer from serious
complications of the disease. In the Amazon region, patients with SCD are attended and assisted
at HEMOAM Foundation, Manaus. However, the clinical characteristics of the SCD patients
attending HEMOAM is still unknown. Hence, the present study was undertaken to characterize
clinical and demographic aspects of SCD patients attending HEMOAM foundation with the goal
of identifying clinical aspects peculiar to this population, as well as providing data for a better
planning of assistance for these patients by the public health managers. The study was crosssectional observational, without intervention. The study population consisted of 122 patients
who were recruited from a total of 236 individuals registered in the institution's historical record.
Of these, 89.7% were homozygous for the presence of HbS (SS), while the rest were presenting
other forms of SCD. The mean age of the population was 15 years and the distribution among
male and female was 52:70. No significant differences were observed regarding to access to
treatment for SCD, although we have observed that patients who live in the interior have been
diagnosed later than those who live in Manaus. About the clinical presentation, the most
6
frequent complication was the lower limb ulcers, reported in 84.5% of patients. The severity of
the SCD, estimated by a internationally validated.The total of our patients is divided into three
groups: 2 to 17 years; 18 to 40 years; And greater than 40 years. Using this division, the severity
scores in our population were 0.34 (0.04-0.89) in patients younger than 18 years, 0.63 (0.20-
0.96) in patients between 18 -40 Years, and 0.80 (0.71-0.97) in patients older than 40 years,in
our population similar to the severity score of the patient population from Rio de Janeiro. The
results obtained allowed us to obtain a comprehensive profile of the demographic, social and
clinical characteristics of SCD in Amazonas, and will be important for the planning assistance to
SCD patients. In addition, we were able to observe the impact of socioeconomic aspects on care,
while showing that essential aspects of SCD treatment seem to be preserved in this population.
Finally, the use of the severity score allowed us to obtain a general clinical picture of the
evolution of SCD in a population with distinct ethnic characteristics from other SCD
populations.